Itay & Beyond

Pioneering biotech startup revolutionizing neuropsychiatric drug discovery through its groundbreaking platform.

Health Tech & Life Sciences
Active
Pre-Funding Jerusalem, Israel Founded 2021
Last updated 2026-08-23
Total raised
—
Stage
Pre-Funding
Founded
2021
Headcount
15
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences

About

Itay & Beyond is an Israeli biotech startup that integrates patient-derived brain organoids with advanced AI analysis to predict drug efficacy for neurological and psychiatric disorders. The company's platform aims to improve drug development by providing accurate human-based models, reducing reliance on animal testing, and enhancing patient outcomes. The company was founded in 2021, inspired by co-founder Shmulik Bezalel's son, Itay, who has Autism Spectrum Disorder (ASD), and the urgent need for more effective treatments for neuropsychiatric disorders. Their technology, validated in a 200-patient study at Hadassah Medical Center, combines patient-derived brain organoids, a bio-dynamic processing unit, and advanced AI analysis to dramatically improve drug efficacy predictions. Itay & Beyond is a neurotech CNS company pioneering patient-derived brain organoid technologies enabling functional brain-on-a-chip readouts and AI-driven analytics for neuropsychiatric and neurological diseases. The company is building a scalable CNS discovery and development platform designed to improve translational predictivity, support disease subpopulation stratification, and accelerate the identification and development of more relevant therapeutic candidates.

Offices

Jerusalem, Israel · HQ / main office

Q&A

What is Itay & Beyond's primary focus?
Itay & Beyond is a biotech startup focused on revolutionizing neuropsychiatric drug discovery using patient-derived lab-grown brain tissue on a chip to develop novel treatments for neurology and psychiatry.
When was Itay & Beyond founded?
Itay & Beyond was founded in January 2021.
How many employees does Itay & Beyond currently have?
Itay & Beyond has 11-50 employees.
What is Itay & Beyond's current funding stage?
Itay & Beyond is currently in the Pre-Funding stage.
Who is the Co-founder and CEO of Itay & Beyond?
Nissim Perets is the Co-founder and CEO of Itay & Beyond.
What is the product stage of Itay & Beyond?
The product stage of Itay & Beyond is R&D.
Where is Itay & Beyond headquartered?
Itay & Beyond is headquartered in Jerusalem, Israel.
What sectors does Itay & Beyond operate in?
Itay & Beyond operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, and Digital Healthcare.

Team · 10

Dr. Nisim Perets
Founder · Co-Founder and CEO
Shmulik Bezalel
Founder · Co-Founder and Investor
Boaz Goldman
Founder · Co-Founder and Investor
Dr. Nir Waiskopf
VP of Research and Development
Dr. Ruth Tal-Singer
Advisory Board Member
Dr. Frida Grynspan
Advisory Board Member
Arie Karmer
Advisory Board Member
Ronen Levi
Advisory Board Member
Dr. Orit Shaked
Advisory Board Member
Prof. Ariel Tenenbaum
Advisory Board Member

Sectors & technology

Primary sector
Health Tech & Life Sciences
Technologies
Target customers

Tags

drug-discoveryneuroscience
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteitayandbeyond.com/
LinkedInlinkedin.com/company/73923110

Identifiers & details

Legal nameItayandbeyond Ltd.
Founded2021
Employees (exact)15

Radar intelligence

Web history (Wayback)

Domainitayandbeyond.com

Certificate / subdomain footprint

Subdomains9